De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
Titel:
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
Auteur:
Guarneri, V. Dieci, M.V. Bisagni, G. Frassoldati, A. Bianchi, G.V. De Salvo, G.L. Orvieto, E. Urso, L. Pascual, T. Paré, L. Galván, P. Ambroggi, M. Giorgi, C.A. Moretti, G. Griguolo, G. Vicini, R. Prat, A. Conte, P.F.